Biography and Research Information
OverviewAI-generated summary
Tsigereda Weldemichael's research focuses on the intersection of pharmacology and cellular damage, particularly in the context of kidney cells. Recent work has investigated how therapeutic agents, specifically EET-based therapeutics, can mitigate damage associated with sorafenib treatment, a known chemotherapy drug. This research has explored the impact of these therapeutics on glomerular cells and podocytes, which are critical components of the kidney's filtration system. Weldemichael's investigations also extend to the molecular mechanisms underlying cancer, with publications examining potent inhibitors of FLT3-ITD mutations, including those resistant to existing treatments like gilteritinib. This work contributes to the understanding of acute myeloid leukemia and the development of targeted therapies. Collaborations include work with Phuc Tran, Abdul H. Khan, Shobanbabu Bommagani, and Abhishek Mishra at the University of Arkansas for Medical Sciences, with shared publications indicating active research partnerships.
Metrics
- h-index: 3
- Publications: 5
- Citations: 69
Selected Publications
-
Renal hemodynamics underlie hepatorenal physiology in bile duct-ligated rats (2026)
-
Renoprotective approaches against anthracycline nephrotoxicity (2026)
-
EET-Based Therapeutics Mitigate Sorafenib-Associated Glomerular Cell Damage (2025)
-
Insect‐Microbe‐Based Laccase: Untapped Natural Resource for Industrial and Biotechnological Applications (2025)
-
CD36-mediated endocytosis of proteolysis-targeting chimeras (2025)
-
An imidazo[1,2-a]pyridine-pyridine derivative potently inhibits FLT3-ITD and FLT3-ITD secondary mutants, including gilteritinib-resistant FLT3-ITD/F691L (2023)
-
Delivery of Oligonucleotides: Efficiency with Lipid Conjugation and Clinical Outcome (2022)
Collaboration Network
Top Collaborators
- Delivery of Oligonucleotides: Efficiency with Lipid Conjugation and Clinical Outcome
- An imidazo[1,2-a]pyridine-pyridine derivative potently inhibits FLT3-ITD and FLT3-ITD secondary mutants, including gilteritinib-resistant FLT3-ITD/F691L
- Delivery of Oligonucleotides: Efficiency with Lipid Conjugation and Clinical Outcome
- An imidazo[1,2-a]pyridine-pyridine derivative potently inhibits FLT3-ITD and FLT3-ITD secondary mutants, including gilteritinib-resistant FLT3-ITD/F691L
- Feedforward Loops: Evolutionary Conserved Network Motifs Redesigned for Synthetic Biology Applications
- Insect‐Microbe‐Based Laccase: Untapped Natural Resource for Industrial and Biotechnological Applications
- Feedforward Loops: Evolutionary Conserved Network Motifs Redesigned for Synthetic Biology Applications
- Insect‐Microbe‐Based Laccase: Untapped Natural Resource for Industrial and Biotechnological Applications
- Delivery of Oligonucleotides: Efficiency with Lipid Conjugation and Clinical Outcome
- An imidazo[1,2-a]pyridine-pyridine derivative potently inhibits FLT3-ITD and FLT3-ITD secondary mutants, including gilteritinib-resistant FLT3-ITD/F691L
- An imidazo[1,2-a]pyridine-pyridine derivative potently inhibits FLT3-ITD and FLT3-ITD secondary mutants, including gilteritinib-resistant FLT3-ITD/F691L
- An imidazo[1,2-a]pyridine-pyridine derivative potently inhibits FLT3-ITD and FLT3-ITD secondary mutants, including gilteritinib-resistant FLT3-ITD/F691L
- An imidazo[1,2-a]pyridine-pyridine derivative potently inhibits FLT3-ITD and FLT3-ITD secondary mutants, including gilteritinib-resistant FLT3-ITD/F691L
- An imidazo[1,2-a]pyridine-pyridine derivative potently inhibits FLT3-ITD and FLT3-ITD secondary mutants, including gilteritinib-resistant FLT3-ITD/F691L
- Insect‐Microbe‐Based Laccase: Untapped Natural Resource for Industrial and Biotechnological Applications
- Insect‐Microbe‐Based Laccase: Untapped Natural Resource for Industrial and Biotechnological Applications
- Insect‐Microbe‐Based Laccase: Untapped Natural Resource for Industrial and Biotechnological Applications
- Insect‐Microbe‐Based Laccase: Untapped Natural Resource for Industrial and Biotechnological Applications
- Insect‐Microbe‐Based Laccase: Untapped Natural Resource for Industrial and Biotechnological Applications
Similar Researchers
Based on overlapping research topics